Bleomycin
Bleomycin for Injection, USP
Approved
Approval ID
6824b1e1-e5fa-4371-ade9-1346e12ab0c7
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 6, 2021
Manufacturers
FDA
NorthStar Rx LLC
DUNS: 830546433
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Bleomycin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code16714-886
Application NumberANDA205030
Product Classification
M
Marketing Category
C73584
G
Generic Name
Bleomycin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, INTRAPLEURAL
Effective DateNovember 20, 2018
FDA Product Classification
INGREDIENTS (1)
BLEOMYCIN SULFATEActive
Quantity: 15 [USP'U] in 1 1
Code: 7DP3NTV15T
Classification: ACTIM
Bleomycin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code16714-908
Application NumberANDA205030
Product Classification
M
Marketing Category
C73584
G
Generic Name
Bleomycin
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS, INTRAPLEURAL
Effective DateNovember 20, 2018
FDA Product Classification
INGREDIENTS (1)
BLEOMYCIN SULFATEActive
Quantity: 30 [USP'U] in 1 1
Code: 7DP3NTV15T
Classification: ACTIM